SecBot SecBot
8-K ·Filed May 7, 2026

CCRN

CROSS COUNTRY HEALTHCARE INC
BULLISH
Impact 8/10
Horizonweeks Processed5mo ago SEC0000950103-26-006921
8-K material event: Items 1.01
Actionable Insight ▲ Bullish

The deal is fully financed with equity commitments and no financing condition, significantly reducing execution risk. The stock should trade near the $13.25 offer price minus a small spread for timing/regulatory risk. Monitor the proxy filing and stockholder vote timeline. The locums divestiture to an affiliate may raise antitrust scrutiny but is structured to be conditioned on closing.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
CCRN ▲ +0.23% at T+20d
LONG call ✓ call won +0.23% · α vs SPY -2.91% · entry $13.09 → $13.12
Next anchor: T+60d due 3mo ago
Entry = T+0 close
May 7, 2026
via day close
T+1d
+0.69%
call +0.69% · α -0.14%
$13.18
settled 6mo ago
T+5d
+0.23%
call +0.23% · α -1.28%
$13.12
settled 6mo ago
T+20d
+0.23%
call +0.23% · α -2.91%
$13.12
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Cross Country Healthcare (CCRN) has agreed to be acquired by Knox Lane in an all-cash transaction valued at $437 million, or $13.25 per share. The deal represents a ~31% premium to the May 6 closing price and ~45% premium to the 90-day VWAP. The merger is expected to close in Q3 2026, subject to stockholder approval and regulatory clearance, and will take the company private.

Key Financial Metrics

Deal Value
$437.0M
Premium
31%
Deal Type
merger

Key Facts

  • Knox Lane to acquire CCRN for $13.25/share in all-cash deal valued at $437M
  • ~31% premium to May 6 closing price; ~45% premium to 90-day VWAP
  • Expected close in Q3 2026; subject to stockholder vote and HSR/antitrust approvals
  • No financing condition; equity commitments from Knox Lane funds are in place
  • Company will cancel Q1 2026 earnings call and 2026 Annual Meeting
  • Company termination fee: $14.2M; Parent regulatory termination fee: $14.2M
  • Knox Lane plans to sell CCRN's locums business to affiliate All Star Healthcare Solutions post-close

Financial Impact

All-cash acquisition valued at $437M; $13.25/share cash consideration

stock priceenterprise valueshare count

Risk Factors

  • Stockholder vote may fail or be delayed
  • HSR/antitrust review could delay or block the transaction
  • Go-shop period could attract a competing bid, though no-shop provisions limit this
  • Litigation from shareholders challenging the deal could cause delays

Market Snapshot

Exchange
Nasdaq
Sector
Services-Help Supply Services
Analyst Consensus
53% bullish (15 analysts)

Investment Themes

Services

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000950103-26-006921
Document: dp246394_8k.htm0000950103-26-006921
Document: dp246394_ex9901.htm0000950103-26-006921
Document: 0000950103-26-006921-index-headers.html0000950103-26-006921
Document: 0000950103-26-006921-index.html0000950103-26-006921
Document: 0000950103-26-006921.txt0000950103-26-006921
10 reports for CCRN
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 3 of 5 best @ T+20▲ +7.18%Mar 4, 2026
Filters
Rows
Reports for CCRN — sortable, filterable
TypeNow
Jul 6, 2026
16w ago
425
NEUTRAL ★ 5/10
$13.20awaiting T+20——
Jul 6, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$13.20awaiting T+20——
Jun 15, 2026
19w ago
DEFM14A
BULLISH ★ 7/10
$13.18 $13.22▲ +0.30%▲ +0.10%—
Jun 3, 2026
20w ago
PREM14A
BULLISH ★ 7/10
$13.19 $13.20▲ +0.08%▲ +1.45%—
May 7, 2026
24w ago
DEFA14A
BULLISH ★ 8/10
$13.18 $13.18· 0.00%▼ −0.02%—
May 7, 2026
24w ago
DEFA14A
BULLISH ★ 8/10
$13.18 $13.18· 0.00%▼ −0.02%—
May 7, 2026
24w ago
8-K
MIXED ★ 6/10
$13.18 $13.18· 0.00%▼ −0.02%—
May 7, 2026
24w ago
8-K
BULLISH ★ 8/10
$13.09 $13.12▲ +0.23%▼ −2.91%—
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$9.96 $13.10▲ +31.53%▲ +27.32%—
Mar 4, 2026
33w ago
8-K
BEARISH ★ 8/10
$9.89 $9.18▲ +7.18%▲ +3.39%—
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (11h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026